A Trial of Guanfacine-er for Cannabis Use Disorder
Public ClinicalTrials.gov record NCT05273567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Controlled Trial of Guanfacine-er for Cannabis Use Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to investigate the effect of guanfacine-ER on reductions in cannabis use and explore its effects on impulsivity and withdrawal through a hybrid in-person and virtual trial of treatment-seeking individuals with Cannabis Use Disorder (CUD), and assessing the feasibility of the virtual components of the study.
Study identification
- NCT ID
- NCT05273567
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 22 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2022
- Primary completion
- Sep 7, 2023
- Completion
- Sep 7, 2023
- Last update posted
- Aug 17, 2026
2022 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| STARS Clinic at Columbia and NYSPI Department of Psychiatry | New York | New York | 10017 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cannabis Use trials
Other public records listing Cannabis Use. Sorted by last update posted; newest first. Not a recommendation.
- NCT07725289: Clinician Practice Companion to Address Youth Substance Use Not yet recruiting
- NCT07701304: Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment Recruiting
- NCT07700849: Brief Family-Based Cannabis Use Intervention for Youth With Early Juvenile Justice Involvement Not yet recruiting
- NCT07694466: Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis Not yet recruiting
- NCT07661446: Cannabis and Opioid Use Disorder, Study 2 Not yet recruiting
- NCT07668635: Cannabis Effects on Opioid Self-Administration Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05273567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 17, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05273567 live on ClinicalTrials.gov.